Treatment of first-trimester pregnancy failure with vaginal misoprostol is effective, well-tolerated, and acceptable to most women, according to a randomized trial.
Treatment of first-trimester pregnancy failure with vaginal misoprostol is effective, well-tolerated, and acceptable to most women, according to a randomized trial.
Over 650 women with early pregnancy failure due to anembryonic gestation, embryonic or fetal death, or incomplete or inevitable spontaneous abortion received either 800 μg of vaginal misoprostol or vacuum aspiration. Researchers administered a second dose of misoprostol on day 3 if expulsion was incomplete and performed vacuum aspiration on day 8 if expulsion was still incomplete.
Of almost 500 women receiving misoprostol, 71% had complete expulsion by day 3 and 84% by day 8. Treatment failed in 16% of the misoprostol group and in 3% of the surgical group. Treatment failure was defined as surgical treatment for the misoprostol group and repeat aspiration for the vacuum group within 30 days of initial treatment.
Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353:761-769.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More